Michael Wilson, MD

Article

Updates in DMTs and MS Economic Burden From ACTRIMS 2022

Author:: Michael Wilson, MD

Publish date: March 18, 2022

Dr Michael Wilson reviews updates from ACTRIMS 2022 on DMTs, autologous stem cell transplant, long-term tolebrutinib results as evident on MRI, and...